Press Release: $hareholder Alert: the M&A Class Action Firm Launches Legal Inquiry for the Merger

Dow Jones
07/15

NEW YORK, July 14, 2026 /PRNewswire/ --

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating

   -- Corebridge Financial, Inc. (NYSE: CRBG)  related to its merger with 
      Equitable Holdings, Inc. Upon closing of the proposed transaction, 
      Corebridge shareholders will own approximately 51% of the combined 
      company. 

ACT NOW. The Shareholder Vote is scheduled for July 30, 2026.

Click here for more info https://monteverdelaw.com/case/corebridge-financial-inc/. It is free and there is no cost or obligation to you.

   -- RE/MAX Holdings, Inc. $(RMAX)$ related to its sale to The Real 
      Brokerage Inc. Under the terms of the proposed transaction, RE/MAX 
      shareholders are expected to receive either 5.152 shares of the combined 
      company or $13.80 in cash per share. 

ACT NOW. The Shareholder Vote is scheduled for August 14, 2026.

Click here for more information https://monteverdelaw.com/case/re-max-holdings-inc/. It is free and there is no cost or obligation to you.

   -- Selectis Health, Inc. (OTCMKTS: GBCS) related to its sale to Black Pearl 
      Equities II, LLC. Under the terms of the proposed transaction, Selectis 
      Health shareholders will receive $5.75 per share in cash. 

ACT NOW. The Tender Offer expires on August 10, 2026.

Click here for more information https://monteverdelaw.com/case/selectis-health-inc/. It is free and there is no cost or obligation to you.

   -- Apogee Therapeutics, Inc. (NASDAQ: APGE) related to its sale to AbbVie 
      Inc. Under the terms of the proposed transaction, Apogee shareholders are 
      expected to receive $135.11 per share in cash. 

ACT NOW. The Shareholder Vote is scheduled for August 11, 2026.

Click here for more info https://monteverdelaw.com/case/apogee-therapeutics-inc/. It is free and there is no cost or obligation to you.

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

   1. Do you file class actions and go to Court? 
 
   2. When was the last time you recovered money for shareholders? 
 
   3. What cases did you recover money in and how much? 

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders...and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.

No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan Monteverde, Esq.

MONTEVERDE & ASSOCIATES PC

The Empire State Building

350 Fifth Ave. Suite 4740

New York, NY 10118

United States of America

jmonteverde@monteverdelaw.com

Tel: (212) 971-1341

Attorney Advertising. $(CUL3)$ 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hareholder-alert-the-ma-class-action-firm-launches-legal-inquiry-for-the-mergercrbg-rmax-gbcs-and-apge-302825503.html

SOURCE Monteverde & Associates PC

 

(END) Dow Jones Newswires

July 14, 2026 16:00 ET

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10